Triple Antibiotic (Melaleuca, Inc.)
Welcome to the PulseAid listing for the Triple Antibiotic drug offered from Melaleuca, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Melaleuca, Inc. |
NON-PROPRIETARY NAME: | Bacitracin zinc and Neomycin and Polymyxin B sulfate |
SUBSTANCE NAME: | BACITRACIN ZINC; NEOMYCIN; POLYMYXIN B SULFATE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | OINTMENT |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 1995-07-01 |
END MARKETING DATE: | 0000-00-00 |
Triple Antibiotic HUMAN OTC DRUG Details:
Item Description | Triple Antibiotic from Melaleuca, Inc. |
LABELER NAME: | Melaleuca, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 500; 3.5; 10000([iU]/g; mg/g; [iU]/g) |
START MARKETING DATE: | 1995-07-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 54473-578_91649003-07b6-4620-a513-dcd1edc3ae32 |
PRODUCT NDC: | 54473-578 |
APPLICATION NUMBER: | part333B |
Other BACITRACIN ZINC; NEOMYCIN; POLYMYXIN B SULFATE Pharmaceutical Manufacturers / Labelers: